OGOsamu Goto

Osamu Goto

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


Osamu Goto has a total of 198 co-authors. Here are the top co-authors by number of shared publications:

  • Katsuhiko Iwakiri

    Department of Gastroenterology, Nippon Medical School, Graduate School of Medicine, Tokyo, Japan

    24 shared publications
  • Yasutoshi Ochiai

    Division of Research and Development for Minimally Invasive Treatment Cancer Center Keio University School of Medicine Tokyo Japan

    23 shared publications
  • Naohisa Yahagi

    Division of Research and Development for Minimally Invasive Treatment Cancer Center, Keio University School of Medicine, Tokyo, Japan

    22 shared publications
  • Eriko Koizumi

    Department of Gastroenterology, Nippon Medical School Graduate School of Medicine, Tokyo, Japan

    19 shared publications
  • Ai Fujimoto

    Division of Research and Development for Minimally Invasive Treatment, Cancer Center, Keio University School of Medicine, Tokyo, Japan

    16 shared publications
  • Jun Omori

    Department of Gastroenterology, Nippon Medical School, Graduate School of Medicine, Tokyo, Japan

    15 shared publications

Latest Publications

  • Response

    by Naohiko Akimoto, Osamu Goto

  • Open Access

    Underlap suturing: a safe closure technique for full-thickness defects using endoscopic hand suturing

    by Yumiko Ishikawa, Kentaro Hara, Haruhiko Cho, Toshiro Iizuka, Osamu Goto

  • Open Access

    Variety and clinical applications of endoscopic closure techniques

    by Osamu Goto, Eriko Koizumi

    Variety and clinical applications of endoscopic closure techniques

  • Linked-color imaging with computer-aided detection and the proximal adenoma miss rate: a randomized tandem trial

    by Naohiko Akimoto, Osamu Goto, Takayoshi Nishimoto, Tsugumi Habu, Ryosuke Inoue, Shun Nakagome, Yuka Shimazu, Aitoshi Hoshimoto, Eriko Koizumi, Kazutoshi Higuchi, et al.


  • Open Access

    Three-dimensional imaging of subepithelial tumors: feasibility and utility in preoperative assessment—a retrospective single-center observational study in Japan

    by Eriko Koizumi, Osamu Goto, Yumiko Ishikawa, Tsugumi Habu, Hiroto Noda, Shun Nakagome, Kazutoshi Higuchi, Katsuhiko Iwakiri

    Background/Aims: Endoscopic ultrasound and conventional computed tomography (CT) are useful for preoperative assessment of subepithelial tumors (SETs). However, surgical approaches are sometimes changed intraoperatively owing to unexpected discrepancies between the planned and actual visualizations of tumors because preoperative images are typically two-dimensional.Methods: In this study, we evaluated the feasibility of morphological evaluation using three-dimensional (3D) reconstruction of SETs and its utility in preoperative assessments. We included 15 lesions with a diameter of 1 to 5 cm that were evaluated by CT and pathologically diagnosed as mesenchymal tumors. We examined the feasibility of 3D reconstruction of lesions by evaluating sphericity using CT images with reference to circularity, which was measured from endoscopic ultrasound still images. Furthermore, the predictability of planned surgery determined using 3D images was investigated.Results: The median lesion diameter was 22 mm. There were 10, 3, and 2 lesions of gastrointestinal stromal tumors, leiomyomas, and schwannomas, respectively. 3D reconstruction was feasible for all lesions, with a median sphericity of 0.85, aligning with the median circularity (0.88). The predictability of the 3D-based surgical approach was 90%.Conclusions: 3D reconstruction of SETs is feasible and useful for preoperative determination of the surgical approach.


  • A multicenter retrospective study on the risk factors of stricture formation after moderate circumferential defect resection in esophageal endoscopic submucosal dissection

    by Tsugumi Habu, Osamu Goto, Toshiyuki Yoshio, Waku Hatta, Akira Dobashi, Noboru Kawata, Atsushi Goto, Tetsuya Sumiyoshi, Yugo Iwaya, Tetsuya Tatsuta, et al.

    Background Endoscopic submucosal dissection (ESD) is an effective treatment for superficial esophageal cancer, but postoperative stenosis remains a considerable concern. Particularly, the probability of stenosis is less investigated in patients with a 50–75% circumferential mucosal defect. We identified the risk factors of postoperative stenosis after moderate circumferential defect resection in esophageal ESD. Methods This multicenter retrospective observational study analyzed data from 513 patients with 50–75% circumferential mucosal defect after esophageal ESD across 19 institutions from April 2018 to March 2022. The risk factors for postoperative esophageal stenosis, including steroid use, were investigated. Results Postoperative stenosis was observed in 28 cases (5%). Multivariate analyses identified prior endoscopic treatment close to the lesion (odds ratio [OR], 5.10), cervical esophageal lesion (OR, 3.97), large circumferential defect (OR, 3.78), and longer procedural duration (OR, 3.83) as the independent risk factors for stenosis formation. In the sensitivity analysis using ridge-penalized logistic regression, only circumferential defect > 5/8 (OR, 3.30; 95% CI 1.56–7.66) and procedure time > 120 min (OR, 3.61; 95% CI 1.39–8.25) remained robust predictors; cervical location and prior endoscopic treatment were shrunk toward the null. Particularly, patients with a prior endoscopic treatment, a cervical esophageal lesion, and more than 5/8 of circumferential defect were likely to have stenosis postoperatively despite steroid use. Conclusion In patients with a 50–75% circumferential mucosal defect after esophageal ESD, steroids were used in > 40% of the patients, with 5% of the patients developing postoperative stenosis. Larger circumferential mucosal defect and longer procedural duration were considered as the most relevant risk factors. Stricture prevention should be more aggressively considered in cases at high-risk for stenosis, even though the mucosal defect area was less than three-fourth of the circumference. Graphical abstract


  • Open Access

    Liver metastatic recurrence after curative endoscopic submucosal dissection for slightly submucosal invasive gastric cancer: A case report and literature review

    by Masahiro Niikawa, Teppei Akimoto, Kumiko Kirita, Yuji Yoshida, Tomomi Okubo, Korenobu Hayama, Tsutomu Hatori, Osamu Goto, Shunji Fujimori, Katsuhiko Iwakiri

    In Japan, differentiated‐type early gastric cancer with submucosal invasion 18F‐fluorodeoxyglucose positron emission tomography/CT revealed metastatic liver tumors in S4, S5, and S8. The liver biopsy specimen showed tubular adenocarcinoma and the findings of immunochemical staining were similar to that of the specimen of prior ESD. Thus, he was diagnosed with multiple liver metastatic recurrences after curative ER. Currently, it has been 3 years and 5 months since ESD and 1 year and 11 months since liver metastatic recurrence, and the patient has survived receiving 5th‐line systemic chemotherapy. Here, we report a rare case of liver metastatic recurrence 18 months after curative ESD for early gastric cancer.


  • Open Access

    Advancements in Endoscopic Treatment for Gastric Subepithelial Tumors

    by Osamu Goto, Kazutoshi Higuchi, Eriko Koizumi, Katsuhiko Iwakiri

    Osamu Goto, Kazutoshi Higuchi, Eriko Koizumi, Katsuhiko Iwakiri. Gut and Liver 2025;19:151-60. https://doi.org/10.5009/gnl240358


  • Open Access

    Efficacy of water pressure method for colorectal endoscopic submucosal dissection: Propensity-score matching analysis

    by Kumiko Kirita, Teppei Akimoto, Masahiro Niikawa, Keiichiro Yoshikata, Shun Nakagome, Tsugumi Habu, Yumiko Ishikawa, Eriko Koizumi, Kazutoshi Higuchi, Hiroto Noda, et al.

    Technical difficulty of endoscopic submucosal dissection (ESD) for colorectal neoplasms has not been resolved. The water pressure method (WPM) is a helpful technique for overcome difficulties with colorectal ESD. We evaluated the efficacy and safety of ESD with WPM (WPM-ESD) for colorectal neoplasms compared with conventional ESD (C-ESD).This was a single-center, retrospective, observational study. Three hundred and eleven colorectal lesions were allocated into the WPM-ESD and the C-ESD groups, which were compared before and after propensity score matching. The main outcomes were procedure time, proportion of R0 resection, and incidence of adverse events (AEs) in the two groups.The WPM-ESD and C-ESD groups were allocated 134 and 177 lesions, respectively, and propensity score matching analysis created 92 matched pairs. Mean procedure time was significantly shorter in the WPM-ESD group (49 ± 26 vs. 58 ± 42 min, P = 0.032). All lesions were resected in one piece and there was no difference in the proportion of en bloc resection (100% vs. 100%) and R0 resection (92% vs. 96%, P = 0.536) or in incidence of intraoperative perforation (2.2% vs. 2.2%) in the two groups.WPM for colorectal ESD may shorten procedure time compared with C-ESD without increasing AEs.


  • Diagnostic ability and adverse events of mucosal incision‐assisted biopsy for gastric subepithelial tumors: Systematic review and meta‐analysis

    by Eriko Koizumi, Osamu Goto, Akihisa Matsuda, Toshiaki Otsuka, Yumiko Ishikawa, Shun Nakagome, Masahiro Niikawa, Tsugumi Habu, Keiichiro Yoshikata, Kumiko Kirita, et al.

    Objectives: This systematic review and meta‐analysis aimed to evaluate the diagnostic ability and examine the efficacy of countermeasures to adverse events of mucosal incision‐assisted biopsy (MIAB) for gastric subepithelial tumors (SETs).Methods: We performed a literature search and identified 533 relevant articles. Eleven articles, including 339 lesions, were ultimately used in the meta‐analysis. The primary end‐point was the pathological diagnostic rate of MIAB for gastric SETs, and the secondary end‐point was the incidence of adverse events. The efficacy of acid secretion inhibitors in preventing postoperative bleeding and that of local injection before incision to prevent perforation were also examined.Results: Nine studies were conducted in Japan and two in South Korea, of which only two were prospective studies. The pooled pathological diagnostic rate of MIAB for gastric SETs was 87.8% (95% confidence interval [CI] 80.2–94.0; I2 = 68.7%). The adverse event rate of the pooled population was 0.2% (95% CI 0–1.4; I2 = 0%). The acid secretion inhibitors significantly reduced postoperative bleeding (odds ratio 0.06, 95% CI 0.01–0.66, P = 0.02). Perforation occurred in 0% and 2.6% of the local and nonlocal injection cohorts, respectively, and the pathological diagnostic rates were 50% and 66.7%, respectively.Conclusions: MIAB is a reliable technique with a favorable diagnostic rate and few adverse events. Acid secretion inhibitors may effectively prevent postoperative bleeding; however, the efficacy of local injection remains unclear. This technique could be an option for tissue sampling in gastric SETs.